This hub covers epilepsy and pregnancy: Seizure control, medication safety, folic acid, and planning before, during, and after pregnancy. Research summaries to support informed decisions.
No. Stopping medication suddenly can be dangerous. Medication decisions should be planned with your neurologist/OB.
Body water, metabolism, and clearance change. Some meds need dose adjustments guided by blood levels.
Not always. Many people remain stable, especially with good adherence and monitoring.
Sleep deprivation is a real risk. Planning shifts and extra support isn’t “extra,” it’s safety.
This prospective, multicenter cohort study followed children to age 6.
This retrospective observational study reviewed 307 pregnancies in women with epilepsy; 276 resulted in live births.
Researchers systematically reviewed clinical practice guidelines for women with epilepsy published in English or Korean from January 2014 through December 2024.
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.
This article discusses a proposed way to personalize dosing of perampanel, a seizure medicine used in drug-resistant epilepsy.
This study looked at whether children had a higher chance of neurodevelopmental disorders if their father used valproate during the 3 months before conception, which is the time period used in the study to represent spermatogenesis.
Researchers looked at whether repeated blood levels of lamotrigine during pregnancy were associated with seizure occurrence during pregnancy or up to 6 weeks after birth, and whether these serial measurements improved prediction of seizure risk beyond baseline clinical factors.
This paper was a scoping review, which means the authors gathered and summarized existing research rather than running one new experiment.
This study looked at whether early brain tests could help identify which babies might later develop epilepsy after a neonatal stroke.